{
  "nctId": "NCT02006758",
  "briefTitle": "Observational Study of the EnligHTN Renal Denervation System in Europe",
  "officialTitle": "EnligHTN European Observational Study",
  "protocolDocument": {
    "nctId": "NCT02006758",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2014-03-25",
    "uploadDate": "2019-06-18T09:08",
    "size": 1675275,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02006758/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [],
  "studyType": "OBSERVATIONAL",
  "enrollmentInfo": {
    "enrollmentCount": 68,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2013-11",
    "completionDate": "2017-05",
    "primaryCompletionDate": "2017-05",
    "firstSubmitDate": "2013-12-05",
    "firstPostDate": "2013-12-10"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Subject is planned to undergo a renal denervation procedure for the treatment of hypertension\n* Subject is ≥18 years of age at time of consent\n* Subject must be able and willing to provide written informed consent\n* Subject must be able and willing to comply with the required follow-up schedule\n* Subject has office SBP ≥ 140 mmHg\n* Subject has established hypertension (diagnosed ≥12 months prior to baseline) and is on a guideline based drug regimen at a stable (≥ 14 days) and a fully tolerated dose consisting of ≥3 anti-hypertensive medications (including 1 diuretic)\n\nExclusion Criteria:\n\n* Subject has known significant renovascular abnormalities such as renal artery stenosis \\> 30%\n* Subject has undergone prior renal angioplasty, renal denervation, indwelling renal stents, and/or abdominal aortic stent grafts\n* Subject has a history of hemodynamically significant valvular heart disease\n* Subject has blood clotting abnormalities\n* Subject life expectancy is \\< 12 months, as determined by the Study Investigator\n* Subject is participating in another clinical study which has the potential to impact his/her hypertension management (pharmaceutical/ device/ homeopathic)\n* Subject is pregnant, nursing, or of childbearing potential and is not using adequate contraceptive methods\n* Subject has active systemic infection\n* Subject has known renal arteries with diameter(s) \\< 4 mm\n* Subject has an estimated GFR \\<45 mL/min per 1.73 m2 using the Modification of Diet in Renal Disease (MDRD) formula\n* Subject had a renal transplant or is awaiting a renal transplant",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Mean Change in Office Systolic Blood Pressure at 6 Months",
        "timeFrame": "Baseline and 6 months"
      }
    ],
    "secondary": [
      {
        "measure": "Assessment of Peri-procedural Adverse Events up Until 30 Days Post Procedure",
        "timeFrame": "30 days"
      },
      {
        "measure": "Mean Change in Office Systolic Blood Pressure at 1 Month",
        "timeFrame": "Baseline and 1 month"
      },
      {
        "measure": "Mean Change in Office Diastolic Blood Pressure at 1 Month",
        "timeFrame": "Baseline and 1 month"
      },
      {
        "measure": "Mean Change in Ambulatory Systolic Blood Pressure at 1 Month",
        "timeFrame": "Baseline and 1 month"
      },
      {
        "measure": "Mean Change in Ambulatory Diastolic Blood Pressure at 1 Month",
        "timeFrame": "Baseline and 1 month"
      },
      {
        "measure": "Percentage of Subjects Achieving Office Systolic Blood Pressure < 140 mmHg at 1 Month",
        "timeFrame": "1 month"
      },
      {
        "measure": "Renal Function Change Based on eGFR (Estimated Glomerular Filtration Rate) at 6 Months",
        "timeFrame": "Baseline and 6 months"
      },
      {
        "measure": "Renal Function Change Based on eGFR (Estimated Glomerular Filtration Rate) at 12 Months",
        "timeFrame": "Baseline and 12 months"
      },
      {
        "measure": "Renovascular Safety at 6 Months (Renal Artery Stenosis)",
        "description": "Assessment of renovascular safety as measured by new renal artery stenosis or aneurysm at the site of ablation.",
        "timeFrame": "6 months"
      },
      {
        "measure": "Mean Change in Office Systolic Blood Pressure at 12 Months",
        "timeFrame": "Baseline and 12 months"
      },
      {
        "measure": "Mean Change in Office Diastolic Blood Pressure at 6 Months",
        "timeFrame": "Baseline and 6 months"
      },
      {
        "measure": "Mean Change in Office Diastolic Blood Pressure at 12 Months",
        "timeFrame": "Baseline and 12 months"
      },
      {
        "measure": "Mean Change in Ambulatory Systolic Blood Pressure at 6 Months",
        "timeFrame": "Baseline and 6 months"
      },
      {
        "measure": "Mean Change in Ambulatory Systolic Blood Pressure at 12 Months",
        "timeFrame": "Baseline and 12 months"
      },
      {
        "measure": "Mean Change in Ambulatory Diastolic Blood Pressure at 6 Months",
        "timeFrame": "Baseline and 6 months"
      },
      {
        "measure": "Mean Change in Ambulatory Diastolic Blood Pressure at 12 Months",
        "timeFrame": "Baseline and 12 months"
      },
      {
        "measure": "Percentage of Participants Achieving Office Systolic Blood Pressure < 140 mmHg at 6 Months",
        "timeFrame": "6 months"
      },
      {
        "measure": "Percentage of Participants Achieving Office Systolic Blood Pressure < 140 mmHg at 12 Months",
        "timeFrame": "12 months"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 18,
      "otherCount": 0,
      "totalCount": 19
    },
    "studyDesign": {
      "phases": [],
      "isRandomized": false,
      "isMasked": true
    },
    "overallComplexityScore": 100,
    "complexityCategory": "Highly Complex"
  },
  "collectionDate": "2025-09-22T02:29:13.258Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}